News blog

CIRM taps biotech exec for number two slot

The California Institute for Regenerative Medicine has chosen Ellen Feigal, a biotechnology executive and drug development expert, as its second-in-command. CIRM president Alan Trounson said the agency is to looking to Feigal to help it make good on its promise to translate basic science into treatments. “The primary aim is really to draw on her expertise in translational and clinical medicine, because that’s a pretty important part of our portfolio now,” Trounson said. Generating a tangible product is becoming ever more crucial for CIRM as the clock runs down on the ten-year lifespan of the agency, which was voted into 

BACK TO ARTICLE

Tell a Friend

Please ensure that your friend is content to receive an email from us with a link to the article. Select the following link to view our Privacy Policy.

BACK TO ARTICLE